Erythrocyte levels in chronic obstructive pulmonary disease (COPD) patients with a history of positive and negative COVID-19
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition that predisposes patients to severe complications when infected with SARS-CoV-2 (COVID-19). Hematological alterations, particularly in erythrocyte levels, may influence the clinical course and outcomes in these high-risk individuals. Objective: This study aimed to evaluate the erythrocyte profile of COPD patients with and without COVID-19 at RS Paru Dr. Ario Wirawan Salatiga.
Methods: An analytic study design was employed. Participants were recruited using consecutive sampling. All COPD patients admitted between March 2019 and December 2023 were included. A total of 53 COPD patients participated, comprising 27 COVID-19-positive and 26 COVID-19-negative patients.
Results: The mean erythrocyte level in the COVID-19-positive COPD group was 4.23 ± 0.73 million/µl, while in the COVID-19-negative COPD group, it was 4.77 ± 0.78 million/µl. Although a statistically significant difference was observed between the two groups (p = 0.012), both values remain within the normal reference range.
Conclusion: Erythrocyte levels in both the COVID-19-positive and COVID-19-negative COPD groups remained within the normal range, although the levels were relatively lower in the COVID-19-positive group with statistical significance. Further research is needed to explore the underlying mechanisms contributing to this difference.
References
The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive summary: Global Strategy for Diagnosis, Management, and Prevention of COPD. Medical Communication Resource. 2020.
David MG Halpin a, Claus F Vogelmeier b, Alvar A Agusti c. COPD & COVID-19. Arch Bronconeumol. 2021 Mar 10;57(3):162–164. https://doi.org/10.1016/j.arbres.2021.01.001
Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia, SKI 2023. Jakarta: Kementerian Kesehatan RI; 2023.
Malay Sarkar 1, Puja Negi Rajta 2, Jasmin Khatana 3. Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact. Lung India. 2015 Mar-Apr;32(2):142-52. https://doi.org/10.4103/0970-2113.152626
Nutritional anaemias. Report of a WHO scientific group World Health Organ TechRep Ser. 2021;405:5–37.
Boutou AK, Stanopoulos I, Pitsiou GG, Kontakiotis T, Kyriazis G, Sichletidis L, et al Anemia of chronicdiseasein chronic obstructive pulmonarydisease: A case-control study of cardiopulmonary exercise responses Respiration. 2011;82:237–45. https://doi.org/10.1159/000326899
John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD Chest. 2020;127:825–9. https://doi.org/10.1378/chest.127.3.825
Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease Cost EffResourAlloc. 2016;4:17. https://doi.org/10.1186/1478-7547-4-17
Chronic Obstructive Pulmonary Disease and Its Effect on Red Blood Cell Indices Sara Tariq , Dina Ismail , Milan Thapa , Lakshmi Goriparthi , Roshini Pradeep , Khizer Khalid , Ayden Charlene Cooper , Gutteridge Jean-Charles. 2023. Cureus 15(3)
Chronic Obstructive Pulmonary Disease (COPD). World Health Organization . 2022.
COPD Trends Brief: Prevalence. American Lung Association . 2020.
Agusti A, Soriano JB: COPD as a systemic disease . COPD. 2018, 5:133-8. https://doi.org/10.1080/15412550801941349
Huang Y, Wang J, Shen J, et al.: Relationship of red cell index with the severity of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2021, 16:825-34. https://doi.org/10.2147/COPD.S292666
Sato K, Inoue S, Ishibashi Y, et al.: Association between low mean corpuscular hemoglobin and prognosis in patients with exacerbation of chronic obstructive pulmonary disease. Respir Investig. 2021, 59:498-504. https://doi.org/10.1016/j.resinv.2021.01.006
Tertemiz KC, Ozgen Alpaydin A, Sevinc C, Ellidokuz H, Acara AC, Cimrin A: Could "red cell distribution width" predict COPD severity?. Rev Port Pneumol 2016, 22:196-201. https://doi.org/10.1016/j.rppnen.2015.11.006
Toft-Petersen AP, Torp-Pedersen C, Weinreich UM, Rasmussen BS: Association between hemoglobin and prognosis in patients admitted to hospital for COPD. Int J Chron Obstruct Pulmon Dis. 2016, 11:2813-20. https://doi.org/10.2147/COPD.S116269
Uertas A, Palange P: COPD: a multifactorial systemic disease . Ther Adv Respir Dis. 2011, 5:217-24. https://doi.org/10.1177/1753465811400490
Global Strategy for the Diagnosis, Management, and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease. 2020.
Duncan D: Chronic obstructive pulmonary disease: an overview . Br J Nurs. 2016, 25:360, 362-6. https://doi.org/10.12968/bjon.2016.25.7.360
Copyright (c) 2025 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
